Apoptosis, a form of programmed cell death, is a highly regulated mechanism involved in cellular homeostasis and organ remodeling. Although sustained inhibition of apoptosis can lead to uncontrolled cell proliferation (neoplasia), a pharmacologic approach that could prevent apoptotic cell death could have a profound beneficial impact in a variety of diseases associated with acute cellular injury. The mitochondria play a fundamental role in the two well-established molecular pathways controlling apoptosis by mediating release of cytochrome c into the cytosol This project will focus on inhibiting cytochrome c redox cycling induced oxidation of cardiolipin by the hemoprotein reductant acetaminophen. The goals of this project are to 1) investigate the mechanisms by which cytochrome c is released following cardiolipin oxidation in mitochondria and 2) establish the efficacy of acetaminophen to inhibit apoptosis in vivo at concentrations that are within the therapeutic range in humans, and 3) identify novel inhibitors of cytochrome c redox cycling as pharmacologic candidates for preventing apoptosis in vivo using an animal model of ischemia/reperfusion injury. These investigations will utilize a conjunction of methods including isolated mitochondria, cells in culture isolated from genetic variants, and various stimuli of apoptosis. The involvement of the two mitochondrial pores in these mechanisms will be tested as well as their relationship with oxidized cardiolipin. Finally, this project will assess the ability of acetaminophen to protect kidneys in vivo from ischemia/reperfusion injury induced apoptosis. Results in this proposal will provide preclinical data necessary for consideration of initial human trials in preventing apoptotic cell death associated with disorders such as myocardial infarction and stroke. Although acetaminophen is effective in inhibiting hemoprotein redox cycling induced lipid peroxidation, it is not the ideal drug for use in humans because of its associated propensity to cause hepatotoxicity, which prohibits dose escalation to enhance efficacy. In this regard, our studies will also evaluate novel synthetic compounds with the goal being to identify new potent inhibitors of cyt c redox cycling that have a high safety margin that could be further developed and eventually tested in humans.

Public Health Relevance

Apoptosis, a form of programmed cell death, is involved in many diseases, including neurodegenerative diseases and ischemic injury following myocardial infarction and stroke. Currently, there are no therapeutic strategies available to directly inhibit the apoptotic process. Showing that acetaminophen can prevent apoptosis at normal human therapeutic concentrations will provide preclinical data necessary for consideration of initial human trials in preventing apoptotic cell death associated with these disorders.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Program Projects (P01)
Project #
5P01GM015431-46
Application #
8489124
Study Section
Special Emphasis Panel (ZGM1-PPBC-6)
Project Start
Project End
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
46
Fiscal Year
2013
Total Cost
$318,845
Indirect Cost
$123,257
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Teder, Tarvi; Boeglin, William E; Brash, Alan R (2017) Oxidation of C18 Hydroxy-Polyunsaturated Fatty Acids to Epoxide or Ketone by Catalase-Related Hemoproteins Activated with Iodosylbenzene. Lipids 52:587-597
Teder, Tarvi; Boeglin, William E; Schneider, Claus et al. (2017) A fungal catalase reacts selectively with the 13S fatty acid hydroperoxide products of the adjacent lipoxygenase gene and exhibits 13S-hydroperoxide-dependent peroxidase activity. Biochim Biophys Acta 1862:706-715
Plewes, Katherine; Kingston, Hugh W F; Ghose, Aniruddha et al. (2017) Cell-free hemoglobin mediated oxidative stress is associated with acute kidney injury and renal replacement therapy in severe falciparum malaria: an observational study. BMC Infect Dis 17:313
Kong, Deping; Li, Juanjuan; Shen, Yujun et al. (2017) Niacin Promotes Cardiac Healing after Myocardial Infarction through Activation of the Myeloid Prostaglandin D2 Receptor Subtype 1. J Pharmacol Exp Ther 360:435-444
Gamble-George, Joyonna Carrie; Baldi, Rita; Halladay, Lindsay et al. (2016) Cyclooxygenase-2 inhibition reduces stress-induced affective pathology. Elife 5:
Adeniji, Adegoke; Uddin, Md Jashim; Zang, Tianzhu et al. (2016) Discovery of (R)-2-(6-Methoxynaphthalen-2-yl)butanoic Acid as a Potent and Selective Aldo-keto Reductase 1C3 Inhibitor. J Med Chem 59:7431-44
Kudalkar, Shalley N; Kingsley, Philip J; Marnett, Lawrence J (2016) Assay of Endocannabinoid Oxidation by Cyclooxygenase-2. Methods Mol Biol 1412:205-15
Wu, Jing; Montaniel, Kim Ramil C; Saleh, Mohamed A et al. (2016) Origin of Matrix-Producing Cells That Contribute to Aortic Fibrosis in Hypertension. Hypertension 67:461-8
Harrison, D G; Guzik, Tomasz J (2016) Macrophages come to mind as keys to cognitive decline. J Clin Invest 126:4393-4395
Montaniel, Kim Ramil C; Harrison, David G (2016) Is Hypertension a Bone Marrow Disease? Circulation 134:1369-1372

Showing the most recent 10 out of 149 publications